CONVIVO Endomicroscopy for Brain Tumors

This study is looking at a new device called CONVIVO to help surgeons during brain tumor removal. CONVIVO is a handheld imaging tool that can show detailed pictures of brain tissue in real-time, like an "optical biopsy." The goal is to see how easy it is for surgeons to use CONVIVO to tell the difference between healthy and abnormal tissue during surgery. This could help them remove as much of the tumor as possible while protecting healthy brain tissue. You might be able to join if you are having surgery for a brain tumor. The study plans to include 30 patients and will check the ease of use of CONVIVO over one year.

Study design
This is an interventional study involving 30 participants. It is designed to investigate the ease of use of the CONVIVO device during brain surgery.
What's involved
You would be participating during your neurosurgery for an intracranial lesion (a growth inside the skull). The CONVIVO device would be used during this surgery.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, ease of CONVIVO, will be measured at one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06087393

CONVIVO Endomicroscopy

Recruiting
NAAll AgesInterventionalDevice feasibility
Northwell Health
~30 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:CONVIVO

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Investigate ease of CONVIVO.
Measured over one year
Brain Tumor
1 sites across 1 states
New York1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

. The patient is suffering from an intracranial lesion requiring surgery:
Patients undergoing neurosurgical resection for intrinsic presumably high grade, invasive tumors.
Patients undergoing neurosurgical resection for other brain tumors,.
All patient groups will only be comprised of elective surgical patients who have signed the informed consent prior to use

Exclusion

History of hypersensitivity to fluorescein
History of allergy or bronchial asthma
Renal failure - Children (patients less than 18 years of age)
Pregnant women
Breast feeding women
Patients with inability to give informed consent
  • Investigate ease of CONVIVO.one year

    The outcome is to investigate and assess the ease of use of the CONVIVO FDA cleared system in discriminating healthy and abnormal tissues during in vivo use on the brain during neurosurgery in 30 patients with a working diagnosis of intrinsic brain tumors.